-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Maintains Outperform on West Pharmaceutical Servs, Raises Price Target to $410

Benzinga·07/06/2026 17:06:25
Listen to the news
Evercore ISI Group analyst Daniel Markowitz maintains West Pharmaceutical Servs (NYSE:WST) with a Outperform and raises the price target from $390 to $410.